Funding for this research was provided by:
Fogarty International Center (U01 TW0101 07)
National Institute of Allergy and Infectious Diseases (1K01AI103544)
Received: 10 August 2020
Accepted: 16 February 2021
First Online: 26 February 2021
: Emory University’s Institutional Review Board reviewed the study protocol and determined that the use of aggregated data in these analyses was exempt from requiring human subjects research approval.
: Not applicable.
: Dr. Lopman reports personal fees from Takeda Pharmaceutical, personal fees from CDC Foundation, personal fees from Hall Booth Smith, P.C., outside the submitted work. All other authors have nothing to disclose.